Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at statnews.com →

More in Health & Medicine

More from Friday 28 August →